CN102908623A - 含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物 - Google Patents

含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物 Download PDF

Info

Publication number
CN102908623A
CN102908623A CN2012104247517A CN201210424751A CN102908623A CN 102908623 A CN102908623 A CN 102908623A CN 2012104247517 A CN2012104247517 A CN 2012104247517A CN 201210424751 A CN201210424751 A CN 201210424751A CN 102908623 A CN102908623 A CN 102908623A
Authority
CN
China
Prior art keywords
calcium
magnesium
zinc
group
dissolubility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012104247517A
Other languages
English (en)
Chinese (zh)
Inventor
谭润球
林鸽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEAUTY PEARL GROUP Ltd
Original Assignee
BEAUTY PEARL GROUP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BEAUTY PEARL GROUP Ltd filed Critical BEAUTY PEARL GROUP Ltd
Publication of CN102908623A publication Critical patent/CN102908623A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pediatric Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CN2012104247517A 2008-01-28 2009-01-28 含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物 Pending CN102908623A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2399708P 2008-01-28 2008-01-28
US61/023997 2008-01-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2009801031150A Division CN101925357B (zh) 2008-01-28 2009-01-28 含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物

Publications (1)

Publication Number Publication Date
CN102908623A true CN102908623A (zh) 2013-02-06

Family

ID=40913349

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2009801031150A Active CN101925357B (zh) 2008-01-28 2009-01-28 含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物
CN2012104247517A Pending CN102908623A (zh) 2008-01-28 2009-01-28 含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN2009801031150A Active CN101925357B (zh) 2008-01-28 2009-01-28 含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物

Country Status (9)

Country Link
US (4) US9308222B2 (enExample)
EP (2) EP2257300B1 (enExample)
JP (2) JP5419298B2 (enExample)
KR (2) KR20150100960A (enExample)
CN (2) CN101925357B (enExample)
AU (1) AU2010212456B2 (enExample)
CA (1) CA2712647C (enExample)
NZ (1) NZ585408A (enExample)
WO (1) WO2009095798A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111787928A (zh) * 2017-07-31 2020-10-16 慧创骨科药品有限公司 提高骨密度的多矿物质补充剂

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150100960A (ko) * 2008-01-28 2015-09-02 뷰티 펄 그룹 리미티드 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
IT1400231B1 (it) * 2010-05-07 2013-05-24 Pharmanutra S R L Effetti dell' associazione di vitamina k2 e vitamina d3 nel consolidamento di una frattura ossea.
ITMI20110771A1 (it) * 2011-05-06 2012-11-07 Pharmanutra S R L Composizione comprendente una associazione di vitamine per uso nel trattamento della algodistrofia.
MX2014000957A (es) * 2011-07-27 2014-04-30 Sinoveda Canada Inc Formulas que comprenden elementos altamente solubles y vitamina para la prevencion y disminucion de osteoporosis.
KR20140054124A (ko) * 2011-07-27 2014-05-08 시노베다 캐나다 인코포레이션 골다공증을 예방 및 개선을 위한 고 용해성 원소들 및 비타민을 포함하는 배합물
CN103416684A (zh) * 2013-08-05 2013-12-04 买世禄 改善骨质增生和关节疼痛的氨基酸结合多种微量元素的保健食品的生产方法
KR102230498B1 (ko) 2019-07-31 2021-03-22 보비씨엔이(주) 골다공증 치료용 수소흡장 칼슘 함유 조성물
KR20250106550A (ko) 2024-01-03 2025-07-10 규 재 유 나노입자경의 탄산칼슘과 탄산마그네슘 제조방법 및 그 방법으로 제조된 골다공증 예방치료제

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1082836A (zh) * 1993-04-07 1994-03-02 苑德仲 制取钙质食品强化剂的方法
US20030190369A1 (en) * 2002-04-09 2003-10-09 Lovett William E. Vitamin formulation for enhancing bone strength

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075499A (en) 1988-11-21 1991-12-24 Board Of Regents, The University Of Texas System Calcium supplementation by dicalcium citrate-lactate
CN1027419C (zh) 1990-08-08 1995-01-18 李久成 醋酸钙的制备方法及用途
TW383223B (en) 1992-07-13 2000-03-01 Shiseido Co Ltd External skin treatment composition
CN1039196C (zh) * 1993-05-28 1998-07-22 李晓焰 从珍珠、贝壳、珊瑚中提取保健钙剂的方法
US6716454B2 (en) 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
IL115241A (en) 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US5514382A (en) 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
JP3438447B2 (ja) * 1994-12-28 2003-08-18 セイコーエプソン株式会社 テープ状記録媒体の印刷装置および印刷方法並びにテープ状記録媒体
US5698222A (en) 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
JPH1014535A (ja) 1996-07-05 1998-01-20 Karunaa:Kk 飲食品用カルシウム剤
US5654011A (en) 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
US6447809B1 (en) 1999-05-11 2002-09-10 Metagenics, Inc. Composition for promoting healthy bone structure
CN1117561C (zh) 1999-07-26 2003-08-13 李久成 复合钙制剂及其制备方法和用途
WO2003013270A2 (en) 2001-08-09 2003-02-20 Rhodia Inc. Calcium dietary supplement
WO2003092666A1 (en) 2002-05-01 2003-11-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Calcium-containing tissue strengthening agents and use thereof
CN1221268C (zh) 2002-10-11 2005-10-05 兰为民 镁钙离子复合制剂及其生产工艺
US8703209B2 (en) 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
US8075910B2 (en) 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
TW200640479A (en) 2005-05-30 2006-12-01 Pin-Hong Li Composition of Chinese medicine
TW200711648A (en) 2005-09-22 2007-04-01 Ching-Shun Wu Vitamins, minerals and regiment of plants for autonomic nervous system (including the vagus nerve) disorder or obstacle
CN101330840A (zh) * 2005-12-20 2008-12-24 爱尔康研究有限公司 用于抑制黄斑变性进展和促进健康视觉的组合物和方法
ITRM20060204A1 (it) 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
JP2008013469A (ja) 2006-07-05 2008-01-24 Takeshi Ogura 海洋ミネラル成分からなる骨粗鬆症治療および／または予防剤
HU227610B1 (en) 2006-09-18 2011-09-28 Richter Gedeon Nyrt Pharmaceutical compositions containing rosuvastatin potassium
TWI516279B (zh) 2010-07-28 2016-01-11 布爾頓國際集團有限公司 預防和改善骨質疏鬆症之含有高可溶性元素及維生素的調配物
KR20150100960A (ko) 2008-01-28 2015-09-02 뷰티 펄 그룹 리미티드 골다공증을 예방 및 개선하기 위한 칼슘, 마그네슘, 아연, 및 비타민 ｄ3을 포함하는 배합물
KR20140054124A (ko) 2011-07-27 2014-05-08 시노베다 캐나다 인코포레이션 골다공증을 예방 및 개선을 위한 고 용해성 원소들 및 비타민을 포함하는 배합물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1082836A (zh) * 1993-04-07 1994-03-02 苑德仲 制取钙质食品强化剂的方法
US20030190369A1 (en) * 2002-04-09 2003-10-09 Lovett William E. Vitamin formulation for enhancing bone strength

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111787928A (zh) * 2017-07-31 2020-10-16 慧创骨科药品有限公司 提高骨密度的多矿物质补充剂

Also Published As

Publication number Publication date
KR101577083B1 (ko) 2015-12-11
CN101925357A (zh) 2010-12-22
EP2257300B1 (en) 2014-08-27
WO2009095798A3 (en) 2009-10-15
US20140154332A1 (en) 2014-06-05
AU2010212456A1 (en) 2010-09-09
KR20150100960A (ko) 2015-09-02
JP5419298B2 (ja) 2014-02-19
US20100292194A1 (en) 2010-11-18
US9308222B2 (en) 2016-04-12
US20140342018A1 (en) 2014-11-20
WO2009095798A2 (en) 2009-08-06
AU2010212456B2 (en) 2013-08-22
JP2011510922A (ja) 2011-04-07
JP2014076995A (ja) 2014-05-01
CA2712647C (en) 2016-08-30
CN101925357B (zh) 2012-12-12
CA2712647A1 (en) 2009-08-06
EP2815751A1 (en) 2014-12-24
NZ585408A (en) 2012-06-29
HK1149206A1 (en) 2011-09-30
EP2257300A2 (en) 2010-12-08
US20110312923A1 (en) 2011-12-22
EP2257300A4 (en) 2012-04-18
KR20100107468A (ko) 2010-10-05

Similar Documents

Publication Publication Date Title
CN101925357B (zh) 含有钙、镁、锌和维生素d3并能预防和改善骨质疏松症的组合物
Goodwin Vitamin D in Cancer Patients: Above All, Do No Harm–2009
CN105288579A (zh) 一种补钙制剂及其制备方法
Kim et al. The effect of chicory fructan fiber on calcium absorption and bone metabolism in Korean postmenopausal women
CN104146260A (zh) 一种增加骨密度的保健食品及其制备方法
AU2012288401B2 (en) Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
RU2379043C2 (ru) Фармацевтическая композиция для профилактики и лечения остеопороза у женщин в период менопаузы
RU2356546C1 (ru) Фармацевтический состав на основе сигетина для профилактики и лечения остеопороза (варианты)
Damayanti et al. The Potential Minerals of Bay Leaf (Syzygium Polyanthum): To Support Woman in Pregnancy and Breastfeeding
HK1149206B (en) Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
CN115251339B (zh) 一种通过调节肠道菌群增加骨密度的功能食品组合物及其制备方法
JP2014523921A (ja) 骨粗鬆症の予防および回復のための高溶解性成分とビタミンを含む製剤
Babkina et al. Correction of Mineral Metabolism Disorders in Young Camels
CN110122862A (zh) 一种降低血糖的特殊医学用途食品及其制备方法
Zakharova et al. Russian children need 2,000-4,000 IU of Vitamin D to get most above 40 ng-Dec 2017
Devirian et al. Boron is probably important to human health–2003
Devirian et al. Vitamin D Life
Klein Focus on Pain Center of Orlando
org Listing et al. The Definitive Guide To Magnesium & Magnesium Supplements

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20130206

RJ01 Rejection of invention patent application after publication